Transcriptomics, metabolomics, and in-silico drug predictions for liver damage in young and aged burn victims
- PMID: 37268765
- PMCID: PMC10238406
- DOI: 10.1038/s42003-023-04964-2
Transcriptomics, metabolomics, and in-silico drug predictions for liver damage in young and aged burn victims
Abstract
Burn induces a systemic response affecting multiple organs, including the liver. Since the liver plays a critical role in metabolic, inflammatory, and immune events, a patient with impaired liver often exhibits poor outcomes. The mortality rate after burns in the elderly population is higher than in any other age group, and studies show that the liver of aged animals is more susceptible to injury after burns. Understanding the aged-specific liver response to burns is fundamental to improving health care. Furthermore, no liver-specific therapy exists to treat burn-induced liver damage highlighting a critical gap in burn injury therapeutics. In this study, we analyzed transcriptomics and metabolomics data from the liver of young and aged mice to identify mechanistic pathways and in-silico predict therapeutic targets to prevent or reverse burn-induced liver damage. Our study highlights pathway interactions and master regulators that underlie the differential liver response to burn injury in young and aged animals.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures




References
-
- Jeschke, M. G., Lopez, O. N. & Finnerty, C. C. In Total Burn Care 259–267.e253 (Elsevier, 2018).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous